Lonza Acquires Biotech Service Provider Algonomics

Lonza integrates Innovative Technology in its Protein Design Services offering

10-Nov-2009 - Lonza strengthens its protein design technology offering for biopharmaceutical development by acquiring Algonomics NV. Algonomics is a contract research organisation providing integrated immunogenicity prediction services to support companies in the development of biotherapeutics. Effective 2 ...

AlgoNomics appoints Philippe Stas as CEO

Founder Dr. Ignace Lasters remains CSO and director of the company

03-Jan-2008 - AlgoNomics NV announced the promotion of Philippe Stas to Chief Executive Officer. Dr. Ignace Lasters, who previously held the position of CEO, will continue as Chief Scientific Officer and assume a role as director of the company. Mr. Stas will concentrate on the continued global expansion of ...

AlgoNomics granted patent rights for Epibase

Immunogenicity screening tool for protein therapeutics granted a European patent.

09-Mar-2007 - AlgoNomics NV announced that notice of grant has been received from the European Patent Office for a key patent covering its Epibase® technology. Epibase® is applied for the immunogenicity screening and optimization of biotherapeutics, such as therapeutic antibodies, biosimilars and vaccines. The ...

Analysis by AlgoNomics reveals that Anticalins have an immunogenicity level comparable to the wild-type human lipocalin

19-Dec-2006 - Pieris AG and AlgoNomics NV announced that AlgoNomics' proprietary platform for T-cell epitope identification, Epibase®, revealed that Pieris' human binding proteins Anticalins® intrinsically have an immunogenicity level comparable to the wild-type human lipocalin, as witnessed by a comparable ...

New technology makes clinical research more precise

13-Dec-2006 - The Flanders Interuniversity Institute for Biotechnology (VIB) and AlgoNomics have joined forces to develop a technology that verifies whether certain proteins induce an immune response in humans. The collaboration between VIB and AlgoNomics has yielded a biological test that supplements the ...

Alligator Bioscience to address immunogenicity with Epibase

10-Oct-2006 - Alligator Bioscience AB and AlgoNomics NV announced that they have entered into a collaboration. AlgoNomics will employ its Epibase® platform to complement Alligator Bioscience in the optimization of therapeutic proteins both in their internal projects and in collaborative projects with ...